A Study of Tasisulam-sodium Versus Paclitaxel as Treatment for Metastatic Melanoma
Status:
Terminated
Trial end date:
2011-03-01
Target enrollment:
Participant gender:
Summary
The primary purpose of this study was to see how tasisulam-sodium affected metastatic
melanoma when compared against paclitaxel as measured by overall survival.